Immunara is developing a novel precision immunotherapy that aims to train the immune system to recognise and eliminate dangers specifically and more effectively
Immunara is developing a novel precision immunotherapy that aims to train the immune system to recognise and eliminate dangers specifically and more effectively. Our approach focuses on selectively delivering immunotherapy components to antigen-presenting cells (APCs) — the ‘teacher cells’ of the immune system that are essential for triggering targeted immune responses using our patented single domain antibodies (SdAb) carriers.